Paul Rava
Overview
Explore the profile of Paul Rava including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
558
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Diamond B, Banson K, Ayash J, Lee P, Shukla U, Jones G, et al.
Adv Radiat Oncol
. 2024 Nov;
9(12):101631.
PMID: 39559260
Purpose: For patients with hepatocellular carcinoma (HCC), stereotactic body radiation therapy (SBRT) has emerged as a locoregional treatment. Our purpose was to report outcomes in patients with HCC with Child-Pugh...
2.
Garg R, Foley K, Movahedi B, Masciocchi M, Bledsoe J, Ding L, et al.
Adv Radiat Oncol
. 2021 Mar;
6(1):100559.
PMID: 33665482
Purpose: For patients with hepatocellular carcinoma awaiting liver transplantation (LT), stereotactic body radiation therapy (SBRT) has emerged as a bridging treatment to ensure patients maintain priority status and eligibility per...
3.
Lee P, Ma Y, Zacharias I, Bozorgzadeh A, Wilson S, Foley K, et al.
Adv Radiat Oncol
. 2020 Oct;
5(5):889-896.
PMID: 33083650
Purpose: Our purpose was to report outcomes in patients with Child-Pugh B or C (CP B/C) hepatocellular carcinoma (HCC) treated with stereotactic body radiation therapy (SBRT). Methods And Materials: Patients...
4.
Varlotto J, Voland R, DeCamp M, Rava P, Fitzgerald T, Maxfield M, et al.
Lung Cancer
. 2020 Jul;
147:115-122.
PMID: 32688194
Background: The Lung Cancer Screening Trial demonstrated improved overall survival (OS) and lung cancer specific survival (LCSS), likely due to finding early-stage NSCLC. The purpose of our investigation is to...
5.
Varlotto J, Emmerick I, Voland R, DeCamp M, Flickinger J, Maddox D, et al.
Front Oncol
. 2020 Jun;
10:417.
PMID: 32528866
To identify the incidence, preoperative risk factors, and prognosis associated with pathologically positive lymph node (pN+) in patients undergoing a sub-lobar resection (SLR). This is a retrospective study using the...
6.
Varlotto J, DiMaio C, Grassberger C, Tangel M, Mackley H, Pavelic M, et al.
Neurooncol Pract
. 2019 Aug;
3(3):173-187.
PMID: 31386091
Craniopharyngioma is a rare tumor that is expected to occur in ∼400 patients/year in the United States. While surgical resection is considered to be the primary treatment when a patient...
7.
Varlotto J, Voland R, McKie K, Flickinger J, DeCamp M, Maddox D, et al.
Cancer Med
. 2018 Mar;
7(4):1211-1220.
PMID: 29533006
To investigate the interrelation between economic, marital, and known histopathologic/therapeutic prognostic factors in presentation and survival of patients with lung cancer in nine different ethnic groups. A retrospective review of...
8.
Rae A, Gorovets D, Rava P, Ebner D, Cielo D, Kinsella T, et al.
Adv Radiat Oncol
. 2017 Jul;
1(4):294-299.
PMID: 28740900
Purpose: Many patients treated with stereotactic radiosurgery (SRS) alone as initial treatment require 1 or more subsequent salvage therapies. This study aimed to determine if commonly used salvage strategies are...
9.
Rava P, Rosenberg J, Jamorabo D, Sioshansi S, DiPetrillo T, Wazer D, et al.
Adv Radiat Oncol
. 2017 Jul;
1(3):141-147.
PMID: 28740883
Objective: Our objective was to report safety and efficacy of stereotactic radiosurgery (SRS) to the surgical bed following resection of brain metastases. Methods: Eighty-seven consecutive patients who underwent cavity-directed SRS...
10.
Koffer P, Chan J, Rava P, Gorovets D, Ebner D, Savir G, et al.
World Neurosurg
. 2017 Apr;
104:589-593.
PMID: 28450235
Purpose/objectives: The outcomes of repeat stereotactic radiosurgery (SRS) after failure of previous SRS are not well established. We report our overall experience using SRS for the retreatment of locally recurrent...